These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6173074)

  • 41. Cationic proteins of human granulocytes. V. Interaction with plasma protease inhibitors.
    Venge P; Olsson I; Odeberg H
    Scand J Clin Lab Invest; 1975 Dec; 35(8):737-44. PubMed ID: 54932
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Two-substrate reaction model for the heparin-catalyzed bovine antithrombin/protease reaction.
    Pletcher CH; Nelsestuen GL
    J Biol Chem; 1983 Jan; 258(2):1086-91. PubMed ID: 6822493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency.
    Bauer KA; Goodman TL; Kass BL; Rosenberg RD
    J Clin Invest; 1985 Aug; 76(2):826-36. PubMed ID: 3875633
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of membrane-type serine protease 1/matriptase by natural and synthetic protease inhibitors.
    Yamasaki Y; Satomi S; Murai N; Tsuzuki S; Fushiki T
    J Nutr Sci Vitaminol (Tokyo); 2003 Feb; 49(1):27-32. PubMed ID: 12882393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of antithrombin III on the activity of the coagulation factors VII, IX and X.
    Osterud B; Miller-Andersson M; Abildgaard U; Prydz H
    Thromb Haemost; 1976 Apr; 35(2):295-304. PubMed ID: 61631
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inactivation of alpha- and beta-thrombin by antithrombin-III, alpha 2-macroglobulin and alpha 1-proteinase inhibitor.
    Machovich R; Borsodi A; Blaskó G; Orakzai SA
    Biochem J; 1977 Nov; 167(2):393-8. PubMed ID: 74248
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences between human and rabbit coagulation factor X-implications for in vivo models of thrombosis.
    Edwards ST; Betz A; James HL; Thompson E; Yonkovich SJ; Sinha U
    Thromb Res; 2002 Apr; 106(1):71-9. PubMed ID: 12165292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of protein C and its distribution between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-macroglobulin, in patients with disseminated intravascular coagulation.
    Scully MF; Toh CH; Hoogendoorn H; Manuel RP; Nesheim ME; Solymoss S; Giles AR
    Thromb Haemost; 1993 May; 69(5):448-53. PubMed ID: 7686692
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blood levels of proteinase inhibitors in pregnancy.
    Walker JE; Campbell DM; Ogston D
    Br J Obstet Gynaecol; 1982 Mar; 89(3):208-10. PubMed ID: 6175337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor.
    de Agostini A; Lijnen HR; Pixley RA; Colman RW; Schapira M
    J Clin Invest; 1984 Jun; 73(6):1542-9. PubMed ID: 6725552
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of sulphated polysaccharides on the alpha 1-antitrypsin inhibition of amidolysis catalysed by coagulation cascade proteinases.
    Long WF; Williamson FB
    Br J Pharmacol; 1981 Jun; 73(2):505-9. PubMed ID: 6113018
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction of horse plasma antithrombin III and alpha 1-proteinase inhibitor with some serine proteinases.
    Koj A; Kurdowska A
    Acta Biol Med Ger; 1981; 40(10-11):1561-70. PubMed ID: 6979142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased heparin sensitivity of cyclohexanedione-modified factor Xa.
    Blaskó G; Machovich R
    Thromb Haemost; 1979 Aug; 42(2):556-63. PubMed ID: 505364
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Procedures for the isolation and characterization of human antithrombin III].
    Trobisch H; Wüst T; Rustige H
    Behring Inst Mitt; 1986 Feb; (79):177-90. PubMed ID: 3718405
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of antithrombin III, alpha 2 macroglobulin and alpha 1 antitrypsin in progressive antithrombin activity of human plasma.
    Lebreton de Vonne T; Mouray H
    Int J Biochem; 1980; 12(3):479-84. PubMed ID: 6158467
    [No Abstract]   [Full Text] [Related]  

  • 56. Serine protease specificity for peptide chromogenic substrates.
    Mattler LE; Bang NU
    Thromb Haemost; 1977 Dec; 38(4):776-92. PubMed ID: 146272
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neutral proteases of human granulocytes. IV. Interaction between human granulocyte collagenase and plasma protease inhibitors.
    Ohlsson K; Olsson I
    J Lab Clin Med; 1977 Feb; 89(2):269-77. PubMed ID: 64576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of plasma protease inhibitors and the secretory leucocyte protease inhibitor on leucocyte elastase-induced consumption of selected plasma proteins in vitro in man.
    Björk P; Axelsson L; Bergenfeldt M; Ohlsson K
    Scand J Clin Lab Invest; 1988 Apr; 48(2):205-11. PubMed ID: 2451859
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A study of antithrombin systems during heparin therapy].
    Boneu B; Immaculato F; Sie P; Caranobe C; Chamontin B; Guittard J
    Nouv Presse Med; 1982 Oct; 11(41):3043-6. PubMed ID: 6183640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies of protease inhibitors in the sera of patients with amyotrophic lateral sclerosis.
    Adachi N; Shoji S
    J Neurol Sci; 1989 Feb; 89(2-3):165-8. PubMed ID: 2466958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.